Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is
Deramiocel (
CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We are also harnessing our proprietary StealthX™ exosome platform to unlock new possibilities in targeted delivery and vaccinology. Every program reflects our commitment to pushing the boundaries of science and delivering life-changing treatments to patients and families who need them most.
The Medical Science Liaison (MSL) Director is a field-based scientific leader responsible for delivering Capricor's scientific engagement strategy across an assigned territory of national and regional KOLs treating Duchenne muscular dystrophy (DMD) and DMD cardiomyopathy. The role focuses on scientific exchange with thought leaders, treatment centers, and academic institutions in neuromuscular disease, cardiology, and pediatric specialty care; identification of clinical and research opportunities; and translation of field insights into Capricor's medical strategy for Deramiocel. This individual partners closely with the Medical Director, VP Medical Affairs, HEOR / RWE, Pharmacovigilance, Clinical Development, and the broader U.S. MSL team.
Responsibilities
• Develop and execute the territory KOL/HCP engagement plan, including identification, mapping, and prioritization of thought leaders, prescribers and treatment centers.
• Deliver scientific presentations and engage in scientific exchange with KOLs and HCPs on Deramiocel clinical data, the DMD cardiomyopathy landscape, and emerging evidence.
• Support advisory boards, scientific symposia, and KOL-led research initiatives.
• Identify and support investigator-initiated studies (IIS) and real-world evidence opportunities in coordination with HEOR / RWE and Medical Director.
• Provide scientific support for medical congresses, including DMD, neuromuscular, cardiology, and rare-disease forums.
• Collect and synthesize field insights on clinical practice, treatment decision-making, and emerging evidence; translate insights into recommendations for medical strategy.
• Provide scientific training and support to internal stakeholders (Sales, Market Access, Patient Services) in compliance with channel and engagement rules.
• Maintain comprehensive scientific fluency on Deramiocel clinical data, DMD natural history, and the broader treatment landscape.
• Ensure timely reporting of adverse events and product complaints in line with company and regulatory processes.
• Document field activities, KOL/HCP engagement, and insights in Capricor's medical CRM in compliance with standards.
• Ensure all activities follow FDA, OIG, PhRMA Code, ACCME, and Capricor compliance standards.
• Perform other duties as may be assigned from time to time.
Required Qualifications
• Advanced clinical degree required (MD, PharmD, PhD, DO, or equivalent).
• 5 to 10 years of MSL experience in biotech / pharma; experience in rare disease, cell / gene therapy, pediatrics, neuromuscular disease, or cardiology preferred.
• Established scientific credibility and ability to engage KOLs in peer-to-peer scientific exchange.
• Strong working knowledge of FDA, OIG, PhRMA Code, ACCME, and MLR review processes.
• Excellent written and verbal scientific communication skills, including ability to deliver complex data to clinical audiences.
• Self-directed execution and the ability to operate independently in a field-based environment.
Preferred Qualifications
• Existing relationships across the DMD treatment center network, neuromuscular community, or pediatric cardiology community.
• Prior launch experience in rare disease, cell / gene therapy, pediatrics, rare cardiology or neuromuscular disease.
• Experience operating in a pre-commercial or early-commercial company.
Competency Definitions
• Strong problem-solving and decision-making ability.
• Vendor management and negotiation skills.
• Ability to work in a fast-paced, rapidly scaling environment.
• Exceptional attention to detail and documentation discipline.
• Ability to influence without authority across cross-functional teams.
Working Conditions
• Field-based (remote) position based in or near the assigned territory; territory geography determined at hire.
• Domestic travel approximately 60 to 75% for KOL engagement, advisory boards, congresses, and internal planning.
• Periodic presence at Capricor's San Diego HQ as required by business need.
Why Capricor?
Capricor Therapeutics is advancing cell and exosome-based therapies with a focus on serious diseases where patients and families need new treatment options. Our work is grounded in scientific rigor, collaboration, and a shared commitment to moving meaningful therapies forward. Joining Capricor means being part of a mission-driven team working at the intersection of innovation, execution, and patient impact.
Come Work With Us
At Capricor, you’ll join a collaborative environment where employees are encouraged to contribute, grow, and help build the systems, science, and operations needed to support our next stage of growth. We value people who are thoughtful, accountable, hands-on, and motivated by work that can make a real difference.
Recruiting Fraud Notice
Capricor does not use Skype for interviews or recruiting activities. Candidates will only be contacted by someone using an official Capricor email address ending in @capricor.com. Capricor will never ask candidates to send money, deposit a check, purchase equipment, or provide payment for any reason as part of the recruiting or onboarding process.
Notice to Recruiting Agencies
Capricor Therapeutics does not accept candidate submissions or referrals from recruiting agencies, staffing firms, or third-party recruiters without express written approval from Talent Acquisition and a fully executed agreement with Capricor. Agencies that contact hiring managers directly, solicit business, or submit candidates without prior approval will not be considered for engagement. Any unsolicited submissions will become the property of Capricor Therapeutics, and no fees will be paid for candidates hired as a result of such submissions. We appreciate your cooperation and respect for this policy.